The Potential Role of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Reducing Pneumonia Severity in Older Adults.

angiotensin-converting enzyme inhibitors aspiration pneumonia beta-blockers community-acquired pneumonia curb-65 score pneumonia severity index

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Apr 2024
Historique:
accepted: 02 04 2024
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 3 5 2024
Statut: epublish

Résumé

Background Understanding the impact of pharmacological therapy on pneumonia severity is crucial for effective clinical management. The impact of angiotensin-converting enzyme inhibitors (ACEis) and beta-blockers (BBs) on pneumonia severity remains unknown, warranting further investigation. Methodology This retrospective study examined the hospital records of inpatients (≥75 years) admitted with community-acquired pneumonia in 2021. Pneumonia severity associated with the use of pre-established ACEi and BB therapy was documented using CURB-65 (confusion, uraemia, respiratory rate, blood pressure, age ≥65 years) and pneumonia severity index (PSI) scores. Descriptive statistics and multivariable linear regression were used to analyse differences across BB therapy, ACEi therapy, their combination, or neither (control group). Results A total of 803 patient records were examined, of whom 382 (47.6%) were male and 421 (52.4%) were female. Sample sizes for each group were as follows: control (n = 492), BB only (n = 185), ACEi only (n = 68), and BB + ACEi (n = 58). Distribution of aspiration pneumonia (AP) versus non-AP for each group, respectively, was control (21.1% vs. 78.9%), BB only (9.7% vs. 90.3%), ACEi only (7.3% vs. 92.7%), and ACEi + BB (12.1% vs. 87.9%). No significant differences in PSI and CURB-65 scores were found between intervention groups even after controlling for patient characteristics and irrespective of AP or non-AP aetiology. Patients with AP had significantly higher CURB-65 (p = 0.026) and PSI scores (p = 0.044) compared to those with non-AP. Conclusions Pre-prescribed ACEi or BB therapy did not appear to be associated with differences in pneumonia severity. There were no differences in pneumonia severity scores with ACEi and BB monotherapy or combined ACEi and BB therapy.

Identifiants

pubmed: 38699106
doi: 10.7759/cureus.57463
pmc: PMC11065118
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e57463

Informations de copyright

Copyright © 2024, Thomas et al.

Déclaration de conflit d'intérêts

The authors have declared financial relationships, which are detailed in the next section.

Auteurs

Heledd Thomas (H)

Elderly Care, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, GBR.

Yuki Yoshimatsu (Y)

Elderly Care, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, GBR.

Trevor Thompson (T)

Centre for Chronic Illness and Ageing, University of Greenwich, London, GBR.

David G Smithard (DG)

Elderly Care, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, GBR.

Classifications MeSH